InsidersTradesSigma
Track the 毕得医药 share price and the full management transaction log of the company, a listed equity based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 毕得医药 has logged 8 public disclosures. Market capitalisation: €5.8bn. The latest transaction was filed on 7 September 2026 (Sale). Among the most active insiders: 戴岚. Every trade is free.
8
Insider Decl.
n/a
Thresholds
€140,710
2 ops.
Buy Volume
€882,485
6 ops.
Sell Volume
33Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,081 of 29,063 companies
51.0
score / 100
Value35
Quality67
FCF yld0.1%
Earn yld2.6%
EV/EBITDA25.8x
ROE9.1%
Gross mgn45%
Net mgn11%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 September 2026
Declarations8 total
8 of 8 declarations
Acerca de 毕得医药
毕得医药 es una empresa del sector sanitario y farmacéutico, que cotiza en la Bolsa de Shanghái. Se centra en el desarrollo y la comercialización de productos farmacéuticos innovadores.